Gálvez-Peralta, Marina <br/><br/>
Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell lines.  [electronic resource] 

 -  Molecular pharmacology  Sep 2008 
 - 724-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1521-0111 
<br/><br/><label>Standard No.: </label>10.1124/mol.108.047787  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Camptothecin--analogs & derivatives<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Checkpoint Kinase 1<br/>DNA, Neoplasm--biosynthesis<br/>Deoxycytidine--analogs & derivatives<br/>Down-Regulation--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>Humans<br/>Irinotecan<br/>Phosphorylation--drug effects<br/>Protein Kinases--metabolism<br/>Protein Processing, Post-Translational--drug effects<br/>RNA, Small Interfering--metabolism<br/>S Phase--drug effects<br/>Tumor Stem Cell Assay<br/>Gemcitabine